The role interplay between mesoporous silica pore volume and surface area and their effect on drug loading capacity

TY - JOUR

T1 - The role interplay between mesoporous silica pore volume and surface area and their effect on drug loading capacity

AU - Bavnhøj, Christoffer G.

AU - Knopp, Matthias M.

AU - Madsen, Cecilie M.

AU - Löbmann, Korbinian

PY - 2019/12/1

Y1 - 2019/12/1

N2 - In this study, the influence of the mesoporous silica (MS) textural properties (surface area, pore diameter, and pore volume) on drug loading capacity (monomolecular loading capacity and pore filling capacity) was investigated theoretically and experimentally using a thermoanalytical method. The loading capacities of three model drugs (celecoxib, cinnarizine, and paracetamol) were determined in five different MS grades of Sylysia® with identical chemical composition, but varying surface area, pore diameter and pore volume. The experimentally determined loading capacities were compared to theoretical loading capacities, calculated based on the surface area and amorphous density of the drugs, and the surface area and pore volume of the MS. The findings of the study showed that the monomolecular loading capacity generally increased with increasing surface area and decreasing pore volume of the MS. However, the MS grade with the highest surface area did not display the highest monomolecular loading capacity for any of the three drugs. This was probably a result of the decreasing pore diameter necessary to accommodate the increasing surface area of the MS i.e., if the pore is smaller than the drug molecule, the drug cannot access the available surface area. For these systems, the amorphous density of the drug and the pore volume of the MS was used to estimate the theoretical pore filling capacity, which was in good agreement with the experimentally determined loading capacity. In conclusion, this study showed that both the pore volume and surface area of the MS will have an influence on the drug loading capacity and that this can be estimated with good accuracy both theoretically and experimentally.

AB - In this study, the influence of the mesoporous silica (MS) textural properties (surface area, pore diameter, and pore volume) on drug loading capacity (monomolecular loading capacity and pore filling capacity) was investigated theoretically and experimentally using a thermoanalytical method. The loading capacities of three model drugs (celecoxib, cinnarizine, and paracetamol) were determined in five different MS grades of Sylysia® with identical chemical composition, but varying surface area, pore diameter and pore volume. The experimentally determined loading capacities were compared to theoretical loading capacities, calculated based on the surface area and amorphous density of the drugs, and the surface area and pore volume of the MS. The findings of the study showed that the monomolecular loading capacity generally increased with increasing surface area and decreasing pore volume of the MS. However, the MS grade with the highest surface area did not display the highest monomolecular loading capacity for any of the three drugs. This was probably a result of the decreasing pore diameter necessary to accommodate the increasing surface area of the MS i.e., if the pore is smaller than the drug molecule, the drug cannot access the available surface area. For these systems, the amorphous density of the drug and the pore volume of the MS was used to estimate the theoretical pore filling capacity, which was in good agreement with the experimentally determined loading capacity. In conclusion, this study showed that both the pore volume and surface area of the MS will have an influence on the drug loading capacity and that this can be estimated with good accuracy both theoretically and experimentally.

KW - Amorphous stability

KW - Differential scanning calorimetry (DSC)

KW - Loading capacity

KW - Mesoporous silica

KW - Poorly soluble drugs

KW - Pore diameter

KW - Pore volume

KW - Surface area

UR - http://www.scopus.com/inward/record.url?scp=85062169270&partnerID=8YFLogxK

U2 - 10.1016/j.ijpx.2019.100008

DO - 10.1016/j.ijpx.2019.100008

M3 - Journal article

C2 - 31517273

AN - SCOPUS:85062169270

SN - 2590-1567

VL - 1

JO - International Journal of Pharmaceutics: X

JF - International Journal of Pharmaceutics: X

M1 - 100008

ER -